APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer’s Disease Risk in a Multiracial Sample

Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals

(2018) Katrine L. Rasmussen et al.   Alzheimers & Dementia

An APOE Haplotype Associated with Decreased ε4 Expression Increases the Risk of Late Onset Alzheimer's Disease

(2018) Francesco Lescai et al.   JOURNAL OF ALZHEIMERS DISEASE

APOE ɛ4, rs405509 and rs440446 promoter and intron-1 polymorphisms and dementia risk in a cohort of elderly Finns – Helsinki Birth Cohort Study

(2018) Ville Rantalainen et al.   NEUROBIOLOGY OF AGING

Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium

(2017) Yeonjung Kim et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Exploration of haplotype research consortium imputation for genome-wide association studies in 20,032 Generation Scotland participants

(2017) Reka Nagy et al.   Genome Medicine

Apolipoprotein E Promoter Polymorphisms and Risk of Alzheimer's Disease: Evidence From Meta-Analysis

(2017) Xiao-Yu Xin et al.   JOURNAL OF ALZHEIMERS DISEASE

The TT allele of rs405509 synergizes with APOE ?4 in the impairment of cognition and its underlying default mode network in non-demented elderly

(2016) Chao Ma et al.   Current Alzheimer Research

Is there a significant interaction effect between apolipoprotein E rs405509 T/T and ε4 genotypes on cognitive impairment and gray matter volume?

(2016) C. Ma et al.   EUROPEAN JOURNAL OF NEUROLOGY

A reference panel of 64,976 haplotypes for genotype imputation

(2016)   NATURE GENETICS

Alcohol Intake and Serum Glucose Levels from the Perspective of a Mendelian Randomization Design: The KCPS-II Biobank

(2016) Yon Ho Jee et al.   PLoS One

Glucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical Thinning

(2015) Jessica M. Foley et al.   American Journal of Alzheimers Disease and Other Dementias

Plasma levels of apolipoprotein E and risk of dementia in the general population

(2015) Katrine L. Rasmussen et al.   ANNALS OF NEUROLOGY

The Effects of an APOE Promoter Polymorphism on Human Cortical Morphology during Nondemented Aging

(2015) Y. Chen et al.   JOURNAL OF NEUROSCIENCE

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population

(2015) Yi-Min Sun et al.   Clinical Interventions in Aging

Conducting Meta-Analyses inRwith themetaforPackage

(2015) Wolfgang Viechtbauer   Journal of Statistical Software

APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease

(2014) Daniel M. Michaelson   Alzheimers & Dementia

Association of Apolipoprotein E Genetic Variation in Alzheimer’s Disease in Indian Population

(2014) Rachna Agarwal et al.   American Journal of Alzheimers Disease and Other Dementias

Hippocampal CA1 deformity is related to symptom severity and antipsychotic dosage in schizophrenia

(2013) Kathrin C. Zierhut et al.   BRAIN

Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ϵ4, and the Risk of Late-Onset Alzheimer Disease in African Americans

(2013) Christiane Reitz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2012 Alzheimer’s disease facts and figures

(2012)   Alzheimers & Dementia

Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease

(2012) Carlos Cruchaga et al.   HUMAN MOLECULAR GENETICS

Neuropsychiatric symptoms, apolipoprotein E gene, and risk of progression to cognitive impairment, no dementia and dementia: the Aging, Demographics, and Memory Study (ADAMS)

(2012) Sherry A. Beaudreau et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study.

(2012) Pascal W. M. Van Gerven et al.   NEUROPSYCHOLOGY

Alzheimer Disease: New Concepts on Its Neurobiology and the Clinical Role Imaging Will Play

(2012) Clifford R. Jack   RADIOLOGY

Design Considerations for Characterizing Psychiatric Trajectories Across the Lifespan: Application to Effects of APOE-ε4 on Cerebral Cortical Thickness in Alzheimer's Disease

(2011) Wesley K. Thompson et al.   AMERICAN JOURNAL OF PSYCHIATRY

The projected effect of risk factor reduction on Alzheimer's disease prevalence

(2011) Deborah E Barnes et al.   LANCET NEUROLOGY

Large-scale genome-wide association studies in east Asians identify new genetic loci influencing metabolic traits

(2011) Young Jin Kim et al.   NATURE GENETICS

High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population

(2011) Afef Achouri Rassas et al.   NEUROLOGICAL SCIENCES

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

(2010) John Q. Trojanowski et al.   Alzheimers & Dementia

A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations

(2010) M. Eto et al.   CLINICAL GENETICS

Effects of ApoE-ɛ4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons

(2010) Fabrice Crivello et al.   NEUROIMAGE

Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism

(2010) Markus Donix et al.   NEUROIMAGE

Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults

(2010) Ming Fan et al.   NEUROSCIENCE LETTERS

D10S1423 identifies a susceptibility locus for Alzheimer's disease (AD7 ) in a prospective, longitudinal, double-blind study of asymptomatic individuals: Results at 14 years

(2009) George S. Zubenko et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Longitudinal Modeling of Age-Related Memory Decline and theAPOEε4 Effect

(2009) Richard J. Caselli et al.   NEW ENGLAND JOURNAL OF MEDICINE